Hospitals & Healthcare Pressreleases

Asian Hospital and Healthcare management offers the most advanced strategies in healthcare, the most significant developments in hospital management, provides information on the latest research in healthcare and medical sciences with a special focus on preventive medicine and healthcare.

Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS Brentuximab Vedotin for CD30Expressing Cutaneous TCell Lymphoma

Saturday, December 03, 2016 Bussinesswire

CAMBRIDGE Mass OSAKA Japan BOTHELL WashBUSINESS WIRE Takeda Pharmaceutical Company Limited TSE4502 and Seattle Genetics Inc NASDAQ SGEN today announced that data from the Phase 3 ALCANZA clinical trial evaluating ADCETRIS brentuximab vedotin in patients wit..

ZIMMER BIOMET ZBH ALERT Johnson Weaver LLP Announces Filing of Class Action Complaint Against Zimmer Biomet Holdings Inc Encourages all Investors to Contact the Firm for Information

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswire Johnson Weaver LLP announces that a class action complaint was filed on behalf of purchasers of Zimmer Biomet Holdings Inc NYSE ZBH securities during the period between September 7 2016 through October 31 2016 the Class Period Zimmer Biomet provides musculoskele..

Bioengineering Innovations Show Promise for Improving Treatments and Drug Delivery

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswireUSNewswire In five studies being presented today during the 58th American Society of Hematology ASH Annual Meeting and Exposition in San Diego researchers are applying advanced biomedical engineering methods to improve the delivery of lifesaving treatments to patient..

After One Dose of Gene Therapy Hemophilia B Patients Maintain NearNormal Levels of Clotting Factor

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswireUSNewswire Researchers are reporting the highest and most sustained levels to date of an essential bloodclotting factor IX in patients with the inherited bleeding disorder hemophilia B After receiving a single dose of an experimental gene therapy in a clinical trial ..

Control Of The Tan Company MassageLuXe Xist Fitness LifeXist And BAM Brands Turned Over To Mark Otter

Saturday, December 03, 2016 PR Newswire

ST LOUIS Dec 3 2016 PRNewswire On April 11 2016 Todd Beckman turned over operational daytoday control of the entire BAM Brands Family to Mark Otter previously aDivision President with the Steak N Shake brand On that date Mr Otter was appointed Chief Operating Officer of BAM Brands Mr Beckman has ..

Sickle Cell Disease Research Shows Progress in Preventing Related Complications and Death

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswireUSNewswire Sickle cell disease SCD is an inherited chronic disorder characterized by rigid sickleshaped red blood cells that get stuck in veins and block blood flow which can cause severe pain stroke organ failure and complications leading to death Each year approxi..

Pairnomix Presents Systematic Approach To Identifying Approved Drugs That May Be Repurposed For Treatment Of Rare Genetic Diseases

Saturday, December 03, 2016 PR Newswire

HOUSTON Dec 3 2016 PRNewswire Pairnomix LLC a genetic research company and member of the PatientEmpowered Precision Medicine Alliance PEPMA recognized by the White House today announced that findings from its first case study of an individualized approach to the identification of candidate therapi..

Novartis SEG101 crizanlizumab formerly SelG1 significantly reduces frequency of sickle cell pain crises in Phase II study

Saturday, December 03, 2016 PR Newswire

EAST HANOVER NJ Dec 3 2016 PRNewswire Results from the Phase II SUSTAIN study show that SEG101 crizanlizumab formerly SelG1 an antiPselectin antibody reduced the median annual rate of sickle cellrelated pain crises SCPC by 453 compared to placebo 163 vs 298 p0010 in patients with or without hydrox..

Studies Advance a More Personalized Approach to Treatment

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswireUSNewswire Studies being presented today during the 58th American Society of Hematology ASH Annual Meeting and Exposition in San Diego aim to bring a more personalized and targeted approach to medicine and empower patients to participate more fully in treatment decis..

St Jude Memphis Marathon Weekend raises 10 million for kids battling cancer other lifethreatening diseases at St Jude Childrens Research Hospital

Saturday, December 03, 2016 PR Newswire

MEMPHIS Tenn Dec 3 2016 PRNewswireUSNewswire On Saturday Dec 3 nearly 23000 participants and 40000 spectators from across the US gathered together to celebrate 15 years and running of the St Jude Memphis Marathon Weekend in support of St Jude Childrens Research Hospital Full marathoners Jason H..

Dr Andre Goy and Cota will present Impact of Charlson Comorbidity Index CCI and Refining the MIPI Index in Mantle Cell Lymphoma at 58th American Society of Hematology Annual Meeting Exposition

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswire Dr Andre Goy Cota board member and President of the John Theurer Cancer Center will present a new study utilizing realworld evidence to demonstrate the importance of comorbidities on outcomes of patients with mantle cell lymphoma at the 58th American Society of Hem..

IMBRUVICA ibrutinib Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma 5Year Analysis and LongTerm RESONATE2 Followup Data at ASH 2016 Show Lasting Efficacy

Saturday, December 03, 2016 PR Newswire

NORTH CHICAGO Ill Dec 3 2016 PRNewswire AbbVie NYSE ABBV a global biopharmaceutical company today announced longterm followup results evaluating up to five years of IMBRUVICA ibrutinib use in patients with chronic lymphocytic leukemiasmall lymphocytic lymphoma CLLSLL In this analysis 89 of treatm..

In Clinical Trials CAR T Cell Immunotherapy Continues to Yield Complete Responses in Children Young Adults with Relapsed and Refractory Leukemia

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswireUSNewswire A highly innovative personalized cellbased treatment for a highrisk form of the most common childhood cancer continues to move through clinical trials Pediatric oncologists from Childrens Hospital of Philadelphia today reported new results using T cell im..

Data at ASH 2016 Show Strong Lasting Efficacy of IMBRUVICA ibrutinib Through Five Years of Treatment for Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL

Saturday, December 03, 2016 PR Newswire

SAN DIEGO AND RARITAN NJ Dec 3 2016 PRNewswire Today Janssen Research Development LLC Janssen announced the longest followup results to date of patients treated with IMBRUVICA ibrutinib for chronic lymphocytic leukemiasmall lymphocytic lymphoma CLLSLL showing high and lasting responses through fi..

Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with rr BALL

Saturday, December 03, 2016 PR Newswire

EAST HANOVER NJ Dec 3 2016 PRNewswire Findings from a Novartis clinical trial ELIANA evaluating efficacy and safety of CTL019 an investigational chimeric antigen receptor T cell CAR T therapy in relapsedrefractory rr pediatric and young adult patients with Bcell acute lymphoblastic leukemia ALL wi..

CSL Behring Presents New Phase III Analysis of IDELVION for Hemophilia B at the 2016 American Society of Hematology Annual Meeting

Saturday, December 03, 2016 PR Newswire

SAN DIEGO Dec 3 2016 PRNewswire Global biotherapeutics leaderCSL Behringtoday announced new results from its Phase III clinical development program evaluating IDELVION Coagulation Factor IX Recombinant Albumin Fusion Protein the companys novel longacting recombinant albumin fusion protein f..

Tenet and UnitedHealthcare Renew National Relationship

Friday, December 02, 2016 Bussinesswire

DALLASBUSINESS WIRE Tenet Healthcare Corporation NYSE THC and UnitedHealthcare NYSE UNH have renewed their national relationship for four years ensuring all UnitedHealthcare commercial and Medicare Advantage plan participants have continued innetwork access to Tenets hospi..

Company Profile for Clearwater Compliance

Friday, December 02, 2016 Bussinesswire

BUSINESS WIRE Clearwater Compliance LLC is a leading provider of healthcare compliance and cyber risk management solutions Its mission is to empower hospitals and health systems to successfully manage healthcares evolving cybersecurity risks and ensure patient safety Exclu..

Asken Diet Launches in Canada After Reaching 1 Million Users in Japan

Friday, December 02, 2016 Bussinesswire

ORANGE CalifBUSINESS WIRE Asken Diet the leading Japanese diet and health app is now available as a free download in Canada bringing the services powerful dietitian artificial intelligence AI to the Google Play and iOS app stores Asken Diet was initially launched in Septem..

Code 3 Emergency Partners Announces First Airport Emergency Room in the World Coming to DFW International Airport

Friday, December 02, 2016 Bussinesswire

FRISCO TexasBUSINESS WIRE On November 3 2016 Friscobased Code 3 Emergency Partners received approval from the Dallas Fort Worth DFW International Airport Board to begin construction of an 8125square foot Freestanding Emergency Center and Urgent Care Facility on 143 acres o..

TOP